• ¾ÆÁ¨´Ù
    • ÇÁ·Î±×·¥
    • Âü°¡ÀÚ ¸®½ºÆ®
    • Ãßõ»ç
  • ½ºÆù¼­/Àü½Ã±â¾÷
    • ½ºÆù¼­
    • Àü½Ã±â¾÷ Ç÷ξîÇ÷£
  • °³ÃÖÁö
  • Æ÷½ºÅÍ
  • ¹®ÀÇ
  • Âü°¡½Åû
Immuno-Oncology Summit 2025

ÄÁÆÛ·±½º ÇÁ·Î±×·¥

Engineering

°øÇÐ ½ºÆ®¸²

  • Display of Biologics
    ¹ÙÀÌ¿À·ÎÁ÷½ºÀÇ µð½ºÇ÷¹ÀÌ
  • Engineering Antibodies
    Ç×ü °øÇÐ
  • Machine Learning Part 2
    ±â°èÇнÀ ÆÄÆ® 2
Targets

Ÿ°Ù ½ºÆ®¸²

  • Antibody-Based Therapies
    Ç×ü ±â¹Ý ÀǾà
  • Emerging Targets
    ½Å±Ô Ÿ°Ù
  • Membrane Protein Targets
    ¸·´Ü¹éÁú Ÿ°Ù

Bispecifics

ÀÌÁ߯¯À̼º ½ºÆ®¸²

  • Safety & Efficacy
    ¾ÈÀü¼º¡¤À¯È¿¼º
  • Advancing Multispecifics
    ´ÙÁß Æ¯À̼º Ç×üÀÇ Áøº¸
  • Engineering Bispecifics
    ÀÌÁ߯¯À̼ºÇ×ü °øÇÐ
Immunotherapy

¸é¿ªÄ¡·á ½ºÆ®¸²

  • Immunoengineering
    ¸é¿ª °øÇÐ
  • Innovative CAR Therapy
    Çõ½ÅÀûÀÎ CAR ¿ä¹ý
  • Next-Gen Immunotherapies
    Â÷¼¼´ë ¸é¿ªÄ¡·á
Analytical

ºÐ¼®¹ý ½ºÆ®¸²

  • Optimisation & Developability
    ÃÖÀûÈ­¡¤°³¹ß °¡´É¼º
  • Analytical Characterisation
    ºÐ¼®¹ý Ư¼º Æò°¡
  • Protein Stability & Formulation
    ´Ü¹éÁú ¾ÈÁ¤¼º¡¤Á¦Çü
Expression

¹ßÇö ½ºÆ®¸²

  • Leveraging Data Science
    µ¥ÀÌÅÍ »çÀ̾𽺠Ȱ¿ë
  • Optimising Expression
    ¹ßÇö ÃÖÀûÈ­
  • Developing Workflows
    ¿öÅ©ÇÃ·Î¿ì °³¹ß
Machine Learning

±â°èÇнÀ ½ºÆ®¸²

  • Intro to Machine Learning
    ±â°èÇнÀ ÀÔ¹®
  • Machine Learning Part 1
    ±â°èÇнÀ ÆÄÆ® 1
  • Machine Learning Part 2
    ±â°èÇнÀ ÆÄÆ® 2
Oncology

Á¾¾ç ½ºÆ®¸²

  • Antibody-Based Therapies
    Ç×ü ±â¹Ý ÀǾà
  • Engineering ADCs
    ADC °øÇÐ
  • Next-Gen Immunotherapies
    Â÷¼¼´ë ¸é¿ªÄ¡·á
Short Courses

Training Seminars
CHI | Cambridge HealthTech Institute

Çѱ¹¾î °ø½Ä»çÀÌÆ® ¿î¿µ : Cambridge Healthtech Institute ÆÄÆ®³Ê (ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀ̼Ç